MacroGenics

MacroGenics discovers, develops, and delivers biologic for the treatment of cancer, autoimmune disorders, and infectious diseases.

Business Model:

Revenue: $93M

Employees: 201-500

Rankings

Detailed MacroGenics Information

Geographic Data

MacroGenics headquarters map

Address: 9704 Medical Center Drive

City: Rockville

State: MD

Zip: 20850

Country: US

Financial Info

Stage:

private equity

Raised Last:

$12M

Raised Total:

$166M

Metrics

3,538,101Website Global Rank

4,145Website Monthly Traffic

Twitter Followers

Description

MacroGenics discovers, develops, and delivers biologic for the treatment of cancer, autoimmune disorders, and infectious diseases.

Contact Phone:
+13012515172

Contact Email:

MacroGenics went public on 10/10/2013 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
10/10/2013

Ticker Symbol:
MGNX

IPO Price:
$16/share

Amount Raised:
$80M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
11/2003 Series A $5M
2/2019 Post-IPO Equity -
7/2008 Series D 4 $12.5M TPG
InterWest Partners
Clarus Ventures
Alta Partners
6/2002 Venture Round 7 $12.6M InterWest Partners
Startech Early Ventures
Real Estate Equities
OrbiMed
MPM Capital
Hunt Ventures
Cogene Ventures
InterWest Partners
10/2008 Series D 14 $25M Nextech Venture
Eli Lilly &a; Company Foundation
Mitsubishi UFJ
Arcus Ventures
TPG
Innovis Investments
Alta Partners
Ventures West
CIDC Consultants
Nextech Venture
Alexandria Real Estate Equities
InterWest Partners
OrbiMed
Red Abbey Venture Partners
RiverVest
Nextech Venture
Eli Lilly &a; Company Foundation
Mitsubishi UFJ
Arcus Ventures
TPG
Innovis Investments
Alta Partners
Ventures West
CIDC Consultants
Nextech Venture
7/2010 Grant 1 $9.8M National Institutes of Health
National Institutes of Health
National Institutes of Health
National Institutes of Health
10/2004 Series B 11 $30.5M Alta Partners
TPG
Vivo Capital
Red Abbey Venture Partners
OrbiMed
MPM Capital
Mithra Ventures
InterWest Partners
Hunt Ventures
Emerging Technology Partners
Cogene Ventures
Alta Partners
TPG
5/2006 Series C 11 $45M Ventures West
TPG
RiverVest
Red Abbey Venture Partners
OrbiMed
MPM Capital
Mithra Ventures
InterWest Partners
Caisse de Depot et Placement du Quebec
Biogen Idec
Ventures West
9/2001 Series A 3 $13.5M OrbiMed
MPM Capital
InterWest Partners
4/2018 Post-IPO Equity $110M
10/2013 IPO $80M
8/2013 Equity $10M Servier
1/2011 Private Equity Round $12M
2/2019 Post-IPO Equity -
Announced Date Name Price
7/2008 Raven Biotechnologies
6/2002 Eliance Biotechnology

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research